Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance Mutations
Journal of Medicinal Chemistry · 09.04.2026 · 69 (7) · 8614-8627
DOI: 10.1021/acs.jmedchem.6c00514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 31.03.2026. Verfasst von Robert L Hudkins und 13 weiteren Autor:innen. Beteiligte Einrichtung: Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 2, Pyrimidines, Drug Design, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Tyra Biosciences, Inc..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States.
ORCID-Profile: Robert L Hudkins, Kirk J Nelson, Isaac D Hoffman
Förderung
- Tyra Biosciences, Inc.
Zitieren
APA
Hudkins, R. L., Allen, E., Iyer, S., Balcer, A., Neal, M., Ye, Q., Rideout, M., Frye, C. B., Nelson, K. J., Hoffman, I. D., Starrett, J. H., Harris, T., Swanson, R. V., & Bensen, D. C. (2026). Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance Mutations. Journal of Medicinal Chemistry, 69(7), 8614-8627. https://doi.org/10.1021/acs.jmedchem.6c00514
Vancouver
Hudkins RL, Allen E, Iyer S, Balcer A, Neal M, Ye Q, et al. Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance Mutations. Journal of Medicinal Chemistry. 2026;69(7):8614-8627. doi:10.1021/acs.jmedchem.6c00514
BibTeX
@article{Hudkins2026,
author = {Hudkins, Robert L and Allen, Eric and Iyer, Samhita and Balcer, Alexandra and Neal, Melissa and Ye, Qing and Rideout, Marc and Frye, Caleb B and Nelson, Kirk J and Hoffman, Isaac D and Starrett, Jacqueline H and Harris, Todd and Swanson, Ronald V and Bensen, Daniel C},
title = {Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance Mutations},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {7},
pages = {8614--8627},
doi = {10.1021/acs.jmedchem.6c00514}
}
EUVIMED